Derivatives of nitrosoureas in treatment of patients with neuroendocrine tumors. Clinical case of successful treatment of patient with disseminated highly differentiated neuroendocrine pancreatic tumor with severe carcinoid syndrome in fourth line of therapy-Reference-Cited by-同舟云学术

Derivatives of nitrosoureas in treatment of patients with neuroendocrine tumors. Clinical case of successful treatment of patient with disseminated highly differentiated neuroendocrine pancreatic tumor with severe carcinoid syndrome in fourth line of therapy

Published:2020-10-10 Issue:20 Volume: Page:38-41
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Bagrova S. G.¹,Emelyanova G. S.²,Gorbunova V. A.¹,Kolomeytseva A. A.³,Lyubimova N. V.¹,Markovich А. A.¹,Besova N. S.¹,Kovalenko Е. I.¹,Artamonova E. V.⁴

Affiliation:

1. National Medical Research Centre of Oncology n.a. N. N. Blokhin

2. Moscow State University of Medicine and Dentistry n.a. A. I. Evdokimov

3. Moscow Research Institute n.a. P. A. Herzen - a Branch of the National Medical Radiological Research Centre

4. Russian National Research Medical University n.a. N.I. Pirogov; Moscow Regional Research Clinical Institute n.a. M.F. Vladimirsky

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference12 articles.

1. . Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008 Jun 20; 26 (18): 3063-72. DOI: 10.1200/JCO.2007.15.4377.

2. Phan AT, Oberg K, Choi J, Harrison LH Jr, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA, Maples WJ. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus); North American Neuroendocrine Tumor Society (NANETS). Pancreas. 2010 Aug; 39 (6): 784-98. DOI: 10.1097/MPA.0b013e3181ec1380.

3. Broder LE, Carter SK.Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients. Ann Intern Med. 1973 Jul; 79 (1): 108-18.

4. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-doxorubicin, streptozo-cin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.N Engl J Med. 1992 Feb 20; 326 (8): 519-23.

5. Moertel CG, Hanley JA, Johnson LA.Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1980 Nov20; 303 (21): 1189-94.